Live feed
Filing
SC 13D/A
SC 13D/A0001013594-19-000385·NOVELION THERAPEUTICS INC.
Schedule 13D ownership disclosure
NOVELION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 67001K202
Event date: 2019-05-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,886,230
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-19-000385
- Form type
- SC 13D/A
- Filer
- NOVELION THERAPEUTICS INC.
- CIK
- CIK 827809
- Filed
- May 24, 2019
- Reporting period
- May 22, 2019
- Description
- Schedule 13D beneficial ownership